Sandoz announces plans to build a Biosimilar Technical Development Center in Slovenia to support future growth of biosimilar pipeline

Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026 New end-to-end drug substance and drug...

Related Keywords

Holzkirchen ,Bayern ,Germany ,Slovenia ,Switzerland ,United States ,Lendava ,Lendava Lendva ,Ljubljana ,Slovenia General ,America ,Julie Masow ,Leslie Pott ,Samir Shah ,Richard Jarvis ,Sloan Simpson ,Nicole Zinsli Somm ,Parag Mahanti ,Satoshi Sugimoto ,Isabella Zinck ,Chris Lewis ,Twitter ,Biosimilar Development Center ,Facebook ,Instagram ,Linkedin ,Exchange Commission ,Novartis ,Sandoz Global Communications ,Sandoz Biopharma Technical Development ,Sandoz Biosimilar Technical Development Center ,Sandoz Biopharma Development Center ,D Abreu Hayling ,Chief Scientific Officer ,Markets ,